Archive: 17/02/2014

Vimizim approved for rare childhood disorder

(HealthDay)—Vimizim (elosulfase alfa) has been approved by the U.S. Food and Drug Administration to treat a rare childhood disorder called Mucopolysaccharidosis Type IVA, also known as Morquio A syndrome.

Feb 17, 2014
popularity0 comments 0

Older Americans are early winners under health law

The quest for health care has been one obstacle after another for many older Americans who lost jobs during the recession. They're unwanted by employers, rejected by insurers, struggling to cover rising medical costs and ...

Feb 17, 2014
popularity0 comments 0